Does USTEKINUMAB Cause Condition aggravated? 4,366 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 4,366 reports of Condition aggravated have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 5.1% of all adverse event reports for USTEKINUMAB.
4,366
Reports of Condition aggravated with USTEKINUMAB
5.1%
of all USTEKINUMAB reports
1,225
Deaths
1,853
Hospitalizations
How Dangerous Is Condition aggravated From USTEKINUMAB?
Of the 4,366 reports, 1,225 (28.1%) resulted in death, 1,853 (42.4%) required hospitalization, and 1,472 (33.7%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 4,366 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which USTEKINUMAB Alternatives Have Lower Condition aggravated Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE